ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:

Dictionar de medicamente online

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dictionar medical online

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Puteti trimite articole cu tema medicala la
adresa de email

Solutie antistress!
Construieste poduri :)
Joc, Construieste podul, Cargo Bridge

Prinde pisica neagra :)
Prinde pisica neagra- Chat Noir - Flash game

Banyu And Ono Begins Phase III Clinical Trials Of A DPP-4 Inhibitor For Type 2 Diabetes Patients

Banyu Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd. will begin Phase III Clinical Trial of Sitagliptin (Development Code: MK-0431/ONO-5435) in Japan.

Sitagliptin is a member of a potentially new class of oral drugs (DPP-4 inhibitors) that enhances the body's ability to lower blood sugar when it is elevated.

In controlled international clinical development studies, sitagliptin demonstrated substantial reduction in blood sugar.

The mechanism of DPP-4 inhibitors is distinct from that of any currently available class of glucose lowering agents.

Banyu was in charge of phase II clinical trial and from phase III onward, sitagliptin will be jointly developed by Banyu and Ono.

By Aki Tsukioka, JCN Staff Writer

Copyright © 2006 JCN. All rights reserved. A division of Japan Corporate News Network KK.

JCN





Banyu ªi Ono Începe studiile clinice de fazã III Din Un inhibitor DPP-4 Pentru diabetului de tip 2 Pacienþii - Banyu And Ono Begins Phase III Clinical Trials Of A DPP-4 Inhibitor For Type 2 Diabetes Patients - articole medicale engleza - startsanatate